2 PTX Assets Chosen in Doherty Institute COVID-19 Program
Filed with ASX · · 4 pages · English
Prescient Therapeutics Limited on 6ix
Earlier from Prescient Therapeutics
- Trading Pause
- Reinstatement to Official Quotation
- PTX signs next-gen anti-cancer platform from Penn & Oxford
- Voluntary Suspension
- Pause in Trading
Later from Prescient Therapeutics
- June 2020 Quarterly Update and Appendix 4C
- PTX-200 AML Trial Progresses to Next Dose Level
- PTX-100 progresses to next cohort in basket clinical study
- PTX Announces Cell Therapy Collaboration with Peter Mac
- Extension of Share Purchase Plan
Follow Prescient Therapeutics into a list and get an email when it puts out news.
Follow Prescient Therapeutics